Skip to main content
. 2013 Sep;84(3):314–324. doi: 10.1124/mol.113.086595

TABLE 2.

Examples of active compounds for FPR1 and FPR2

FPR1
FPR2
Compound No.
Binding Ki
Agonist EC50
Antagonist IC50
Binding Ki
Agonist EC50
Antagonist IC50
nM
Pyrrolidine bis-diketopiperazine scaffold
Inline graphic
  a: 1754-113 3 a 1,070 b a c
Inline graphic
      b: 1754-56 2 a 139 1,320 1,300 NA
Inline graphicc: 1754-26 46 a 2,680 70 a 3,480
Inline graphic
      d: 1754-20 b a c 15 a 452
Inline graphic
      e: 1754-19 3,370 a c 6 a 1,410
Inline graphic
      f: 1754-31 b a c 1 a 81
Inline graphic
      g: 1754-49 2,320 a c 33 144 NA
Polyphenylurea scaffold
Inline graphic
      h: 1753-103 4 131 NA b a c

NA, not applicable.

a

No agonistic activity at up to 12 µM.

b

Ki greater than 10,000 nM.

c

No antagonistic activity at up to 10 µM.